
    
      The objective of this observational study is to provide additional data to confirm the safety
      profile and efficacy of low dose FCR for CLL patients treated in clinical practice.

      Specific data of interest are: comorbid concitions, concomitant medication, CLL
      characteristics, prior treatment regimens, adverse events, reasons for discontinuation low
      dose FCR, overal response rates, complete response rate, progression-free survival, overall
      survival.

      This is an observational, non-interventional, medical record review study in CLL patients. A
      total of 200 patients with CLL who have been previously treated with low dose FCR will be
      eligible for the study.
    
  